Condition: Rare Malignant Neoplasm · Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
The goal of this observational study is to collect structured data about diagnosis, treatment and follow-up of rare and highly complex neoplasms. The study has a rerospective part that will consist in gathering data on patients accessing IRCCS Azienda Ospedaliero-Universitaria di Bologna Policlinico di S. Orsola from 01/01/2000 to 28/09/2017 and a prospective one ranging from 29/09/2017 to 31/12/2025.
This description comes directly from the study's public registry record.
Maria A Pantaleo, MD · +39 051 214 · maria.pantaleo@unibo.it
Always discuss trial participation with your own doctor first.
| Oncology Unit, IRCCS AOUBO Policlinico di S. Orsola | Bologna, BO, Italy | Recruiting |
| Thoracic Surgery Unit | Bologna, BO, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06872853